| pubmed-article:6164663 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0345904 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0279000 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0019145 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C1947917 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C1883256 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0205187 | lld:lifeskim |
| pubmed-article:6164663 | lifeskim:mentions | umls-concept:C0205374 | lld:lifeskim |
| pubmed-article:6164663 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6164663 | pubmed:dateCreated | 1981-7-9 | lld:pubmed |
| pubmed-article:6164663 | pubmed:abstractText | Fourteen patients with diffuse tumors of the liver were treated with temporary occlusion of the hepatic artery (HA) by an external tourniquet followed by infusion and systemic chemotherapy. Three patients had primary neoplasms (one hepatocarcinoma and two cholangiocarcinomas) and eleven had metastatic disease (nine from carcinoma of the colon and rectum, one from retroperitoneal liposarcoma, and one from pulmonary small cell cancer). Infusion chemotherapy in all patients was based on 5-FU, Mitomycin and Vincristine. Systemic chemotherapy was FIVB in metastatic carcinoma and Adriamycin in primary liver tumors. All patients showed improvement of the performance status according to the Karnofsky Index. Objective response (OR) was present in 54% of cases. At present, median survival time in 12.5 months. Aggressive treatment combining hepatic ischemia with infusion and systemic polychemotherapy seems to provide an effective method of palliation in diffuse tumors of the liver. Delayed occlusion by an external tourniquet appears safer than intraoperative ligation of the HA. | lld:pubmed |
| pubmed-article:6164663 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6164663 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6164663 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6164663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6164663 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6164663 | pubmed:issn | 0020-8868 | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:CecchettoAA | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:LiseMM | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:FeltrinGG | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:NittsRR | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:FosserVV | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:RubaltelliLL | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:CagolP PPP | lld:pubmed |
| pubmed-article:6164663 | pubmed:author | pubmed-author:PucciarelliSS | lld:pubmed |
| pubmed-article:6164663 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6164663 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:6164663 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6164663 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6164663 | pubmed:pagination | 315-23 | lld:pubmed |
| pubmed-article:6164663 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:meshHeading | pubmed-meshheading:6164663-... | lld:pubmed |
| pubmed-article:6164663 | pubmed:articleTitle | Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. | lld:pubmed |
| pubmed-article:6164663 | pubmed:publicationType | Journal Article | lld:pubmed |
